pISSN 2508-6235 eISSN 2508-7576

Download original image
Fig. 1. Possible mechanisms of the positive effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) on non-alcoholic fatty liver disease. Hollow arrows indicate uncertain mechanisms.
J Obes Metab Syndr 2019;28:18~29 https://doi.org/10.7570/jomes.2019.28.1.18
© JOMES